Trial Profile
Phase I Clinical Study of a Combined Modality Treatment of Sarcomas of the Extremities With Radiotherapy (RT) and Dose-escalation of Pazopanib
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions
- 30 Mar 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 22 Nov 2013 New trial record